title: Continuing methadone for pain in palliative care.
abstract: BACKGROUND
  Methadone is one of the most important medications used for the treatment of refractory pain in the palliative care setting, and is usually initially prescribed by one of a limited number of physicians who have acquired authorization for its use. A lack of authorized physicians able to take over prescribing when the patient is stable is a barrier to accessing methadone for analgesia.
  
  
  OBJECTIVE
  To determine the barriers to family physicians becoming authorized to prescribe methadone for pain in palliative care.
  
  
  METHODS
  A survey exploring the perceived barriers to continuing methadone for pain in palliative care following initial prescription by a specialist was mailed to a randomly selected group of 870 family physicians in British Columbia.
  
  
  RESULTS
  The response rate was 30.9%. Of the 204 responding physicians, 76.1% described themselves as positioned to provide ongoing palliative care to their patients. Within this group, 38 (18.6%) were already authorized to prescribe methadone for pain. The remaining 166 (81.4%) had significant knowledge deficits regarding methadone use in palliative care, but were largely aware of their deficits, and more than one-half were willing to learn more and to obtain an authorization if requested.
  
  
  CONCLUSIONS
  Responding family physicians had mostly received little education regarding methadone for pain, but were aware of their need for education and were willing to learn. Physicians who had already become authorized were generally satisfied with the process of authorization, and believed the process of education through authorization was appropriate and not onerous.
authors: Department of Family Practice, Faculty of Medicine, University of British Columbia. phawley@bccancer.bc.ca
authors: Philippa
authors: P
authors: Hawley
authors: Ryan
authors: R
authors: Liebscher
authors: Jessica
authors: J
authors: Wilford
mesh_terms: D000328:Adult; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D001955:British Columbia; D005260:Female; D006306:Health Surveys; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy*; D010166:Palliative Care; D010820:Physicians / Q000523:psychology*
chemical_list: D000701:Analgesics, Opioid; D008691:Methadone
references: Curr Opin Support Palliat Care. 2009 Dec;3(4):252-7
references: 19797957
references: J Pain Palliat Care Pharmacother. 2002;16(1):29-59
references: 14650449
references: Pain Res Manag. 2004 Winter;9(4):188-94
references: 15605132
references: Pain Res Manag. 2004 Winter;9(4):195-201
references: 15605133
references: BMC Health Serv Res. 2009 Sep 14;9:160
references: 19751504
references: Palliat Support Care. 2003 Dec;1(4):345-52
references: 16594224
references: Pain Res Manag. 2013 Mar-Apr;18(2):83-6
references: 23662290
references: Ann Intern Med. 1993 Jul 15;119(2):121-6
references: 8099769
references: Medicina (Kaunas). 2009;45(6):427-33
references: 19605961
references: Support Care Cancer. 2009 May;17(5):607-12
references: 19043743
references: Cancer. 1995 Dec 1;76(11):2375-82
references: 8635046
references: Clin Ther. 2007;29 Suppl:2589-602
references: 18164924
references: Eval Health Prof. 2007 Dec;30(4):303-21
references: 17986667
references: J Palliat Care. 2001 Summer;17(2):117-20
references: 11477986
references: Support Care Cancer. 2001 Mar;9(2):73-83
references: 11305074